Discovering a new layer of control for a decades-old leukemia drug

Дата публикации: 12-08-2026 22:00:01

For more than 70 years, the drug 6-thioguanine (6-TG) has been used to treat leukemia. Although its clinical effects have been studied extensively, scientists are still uncovering the molecular mechanisms that determine whether cells succumb to the drug or survive its attack.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Inhibiting protein to treat myeloproliferative neoplasms shows preclinical promise	5	7	12-07-2026
2	'Locked' cancer therapeutic activates in tumors, limiting off-target exposure in mice	0	10.95	13-08-2026
3	U of G Prof Discovers Plant-Based Solution to Target Leukemia Weakness	0	19.09	19-06-2026
4	Team finds way to reverse ovarian cancer’s chemo resistance	5	8	25-06-2026
5	Malaga searches for 'switch' that halts most aggressive phase of blood cancer	0	10	13-05-2026
6	Scientists create “smart” DNA drug that targets cancer cells with extreme precision	0	6.52	02-04-2026
7	Найден идеальный «ключ» для обхода защиты устойчивых опухолевых клеток	1	9.61	16-07-2026
8	Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival	0	7.13	04-06-2026
9	Ученые создали новый метод лечения опухолевых заболеваний	0	0	06-09-2019

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 9.64. Источник: medicalxpress.com.